Infections caused by Stenotrophomonas maltophilia (SMA) in patients in intensive care units: A prospective case-control study;Infektionen durch Stenotrophomonas maltophilia (SMA) bei intensivpatienten - Eine prospektive fall-kontrollstudie

Deutsche Medizinische Wochenschrift

Volumn 126, Issue 18, 2001, Pages 514-518

  Raffenberg, M ^a   Szymanski, T ^a   Lubasch, A ^a   Erbes, R ^a   Wagner, S ^a   Weist, K ^a   Mansmann, U ^b   Lode, H ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CARBAPENEM; CEFACLOR; CEFEPIME; CEFOTAXIME; CEFOTIAM; CEFTAZIDIME; CIPROFLOXACIN; CLINAFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; GENTAMICIN; IMIPENEM; TIMENTIN; TOBRAMYCIN;

ADULT; AGED; ARTICLE; BACTERIUM CULTURE; BRONCHUS SECRETION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; FEMALE; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; STENOTROPHOMONAS MALTOPHILIA;

ADULT; AGED; APACHE; CASE-CONTROL STUDIES; CROSS INFECTION; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; LUNG DISEASES, OBSTRUCTIVE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; PROSPECTIVE STUDIES; RISK FACTORS; STENOTROPHOMONAS MALTOPHILIA;

EID: 0035805151     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-13294     Document Type: Article

References (26)

1. Two consecutive outbreaks of Stenotrophomonas maltophilia (Xanthomonas maltophilia) in an intensive care unit defined by restriction fragment-length polymorphism typing
2. Hospital-acquired pneumonia in adults: Diagnosis assessment of severity, initial antimicrobial therapy, and preventative strategies - A consensus statement
3. A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure
4. Nosocomial pneumonia in the intensive care unit: Mechanisms and significance
5. Preventing nosocomial pneumonia: State of the art and perspectives for the 1990s
6. Microbiologiecal and clinical aspects of infection associated with Stenotrophomonas maltophilia
7. Molecular epidemiology of acquisition of ceftazideme-resistant gram-negative bacilli in a nonoutbreak setting
8. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial
9. Association of noninvasive ventilation with nosocomial infections and survival in critically ill patients
10. Stenotrophomonas maltophilia infection and colonization in the intensive care units of two community hospitals: A study of 143 patients
11. Multicenter study using standardized protocols and reagents for evaluation of reproducibility of PCR-based fingerprinting of Acinetobacter spp
12. Antibiotic resistance in the intensive care unit
13. A randomized, controlled trial of protocol-directed versus physician-directed weaning from mechanical ventilation
14. Inadequate antimicrobial treatment of infections: A risk factor for hospital mortality among critically ill patients
15. The effect of late-onset ventilator-associated pneumonia in determining patient mortality
16. Avoidance of tracheal intubation as a strategy to prevent ventilator-associated pneumonia
17. Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: A prospective muli-center study of 91 episodes
18. Noninvasive mechanical ventilation in the weaning of patients with respiratory failure due to chronic obstructive pulmonary disease. A randomized controlled trial
19. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System
20. The increase in carbapenem use and emergence of Stenotrophomonas maltophilia as an important nosocomial pathogen
21. How to select and interpret molecular strain typing methods for epidemiological studies of bacterial infections: A review for healthcare epidemiologists
22. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria
23. Risk factors associated with isolation of Stenotrophomonas (Xanthomonas) maltophilia in clinical specimens
24. The clinical spectrum of Stenotrophomonas (Xanthomonas) maltophilia respiratory infection
25. The prevalence of nosocomial infection in intensive care units in Europe: Results of the European Prevalence of Infection in Intensive Care (EPIC) Study
26. Comparative activity of new quinolones against 326 clinical isolates of Stenotrophomonas maltophilia